Lilly's Lechleiter on Company Growth, Regulation

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

Jan. 9 (Bloomberg) -- John Lechleiter, chief executive officer of Eli Lilly & Co., talks about the outlook for the company as it faces patent expiration on several drugs, growth strategy and government regulation of the industry. Lechleiter speaks with Shannon Pettypiece from the J.P. Morgan Healthcare Conference in San Francisco on Bloomberg Television's "InBusiness With Margaret Brennan." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change